LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

ResMed Inc

Abrir

SetorSaúde

258.4 0.35

Visão Geral

Variação de preço das ações

24h

Atual

Mín

253.75

Máximo

258.71

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

25.434

66.845

Rendimento de Dividendos

0.88

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+16.8% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.88%

2.25%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

280M

38B

Abertura anterior

258.05

Fecho anterior

258.4

Sentimento de Notícias

By Acuity

46%

54%

146 / 352 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de mar. de 2026, 18:43 UTC

Notícias Principais

Fed's Kashkari Says Too Soon To Know Inflation Impact From Middle East Conflict

3 de mar. de 2026, 17:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Ziff Davis to Sell Connectivity Division to Accenture for $1.2 Billion -- Update

3 de mar. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Fall on Continued Concerns About Energy Costs -- Market Talk

3 de mar. de 2026, 23:44 UTC

Conversa de Mercado
Notícias Principais

Gold Rises on Possible Dip-Buying Amid Ongoing Middle East Conflict -- Market Talk

3 de mar. de 2026, 23:25 UTC

Conversa de Mercado

Bannerman Energy Likely to Raise Less Equity for Uranium Projects -- Market Talk

3 de mar. de 2026, 23:25 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

3 de mar. de 2026, 22:38 UTC

Notícias Principais

Iran Conflict Pushes Europe Toward Fresh Energy Crisis -- WSJ

3 de mar. de 2026, 22:16 UTC

Ganhos

Berkshire Provides Scant Fourth-Quarter Financials. Investors Need to Do Their Own Calculations. -- Barrons.com

3 de mar. de 2026, 22:09 UTC

Ganhos

Century Aluminum Changed Historical Method of Proportionately Consolidating Jamalco Production Assets to a Full Consolidation

3 de mar. de 2026, 22:06 UTC

Ganhos

Century Aluminum: Accounting Change for 2023 and 2024 Doesn't Impact Net Income Attributable to Century Stockholders

3 de mar. de 2026, 22:05 UTC

Ganhos

Century Aluminum Initially Concluded That an Accounting Change Was Immaterial, SEC Staff Disagreed With Company's Materiality Conclusion

3 de mar. de 2026, 22:03 UTC

Ganhos

Century Aluminum to Restate Certain Results in Connection Wtih Accounting Change for Jamalco

3 de mar. de 2026, 21:50 UTC

Conversa de Mercado
Notícias Principais

Tech, Media & Telecom Roundup: Market Talk

3 de mar. de 2026, 21:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

3 de mar. de 2026, 21:45 UTC

Notícias Principais

The Iran War Puts the Fed's Rate-Cut Timeline in Doubt -- Barrons.com

3 de mar. de 2026, 21:37 UTC

Ganhos

EVgo Stock Rises as Earnings Defy EV Slump. The Rest of 2026 Doesn't Look So Rosy. -- Barrons.com

3 de mar. de 2026, 21:26 UTC

Notícias Principais

Freeport McMoRan Stock Slides as the Mideast Conflict Hits Commodities -- Barrons.com

3 de mar. de 2026, 20:31 UTC

Conversa de Mercado
Notícias Principais

U.S. Natural Gas Gains on Middle East Turmoil, Weather Outlook -- Market Talk

3 de mar. de 2026, 20:04 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Pull Back as Trump Offers Shipping Protection -- Market Talk

3 de mar. de 2026, 19:17 UTC

Conversa de Mercado
Notícias Principais

Gold and Silver Drop as Energy Surges -- Market Talk

3 de mar. de 2026, 18:43 UTC

Ganhos

Berkshire CEO Abel Is Fond of Financial Metric Similar to One Criticized by Buffett -- Barrons.com

3 de mar. de 2026, 18:29 UTC

Conversa de Mercado
Notícias Principais

Global Energy Roundup: Market Talk

3 de mar. de 2026, 18:29 UTC

Conversa de Mercado
Notícias Principais

Norsk Hydro Announces Stoppage of Qatar Aluminum Smelter -- Market Talk

3 de mar. de 2026, 18:22 UTC

Notícias Principais

Fed's Kashkari on March Projections: Had a Lot of Confidence Up Until a Few Days Ago

3 de mar. de 2026, 18:22 UTC

Notícias Principais

Fed's Kashkari: Too Soon to Know Impact Iran Conflict Will Have on Inflation

3 de mar. de 2026, 18:17 UTC

Conversa de Mercado
Notícias Principais

Strait of Hormuz Standstill Keeps Bid in Oil Futures -- Market Talk

3 de mar. de 2026, 18:14 UTC

Ganhos

How Long Can Anthropic Play Defense? -- WSJ

3 de mar. de 2026, 17:41 UTC

Notícias Principais

Exxon Is Down Since the Iran Conflict. These Energy Stocks Are Bigger Winners. -- Barrons.com

3 de mar. de 2026, 17:36 UTC

Notícias Principais

Iran Conflict is Starting to Boost Gasoline Prices -- Update

3 de mar. de 2026, 17:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Tinicum, Blackstone to Make Decision on Offer By End of Day March 31

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

16.8% parte superior

Previsão para 12 meses

Média 300.64 USD  16.8%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

146 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat